Vir Biotechnology, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vir Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Vir Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$214M, a 30.8% decline year-over-year.
  • Vir Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$533M, a 11.2% increase year-over-year.
  • Vir Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$615M, a 219% decline from 2022.
  • Vir Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $516M, a 2.41% decline from 2021.
  • Vir Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $529M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$615M -$1.13B -219% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $516M -$12.7M -2.41% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $529M +$827M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$299M -$124M -71% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$175M -$58.8M -50.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$116M -$46M -65.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$69.9M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.